The goal of this research study is to compare a combination of two drugs, capecitabine and elacestrant to capecitabine alone as a treatment for advanced estrog…

Estrogen-receptor-positive Breast CancerMetastatic Breast CancerBreast Cancer+6 more

~Estimated

~$10 – $7,500

Kristina A. FanucciNCT07222215

Phase 1

A Pilot Study of FES Imaging to Optimize Tamoxifen Dose for Metastatic Breast Cancer Patients With ESR1 Mutations

Despite broad advancements in endocrine therapy for ERα+ breast cancer, resistance ultimately develops. A common driver of resistance are known ESR1 mutations …

ERα+ Breast CancerESR1 Gene Mutation

~Estimated

~$10 – $6,250

University of Wisconsin, MadisonNCT04174352